Andrea Macko writes in Porcupine Soup that GlaxoSmithKline Consumer Healthcare Holdings filed a lawsuit July 27 against the Town of Durham over their differing views of the worth of the company's Oak Hill business. The town assessed the value of the property at $38,558,100, while GlaxoSmithKline officials say it should be $10,200,000. The 71-acre property on State Route 145 includes a 80,550-square-foot manufacturing facility. The company's lawsuit claims the assesment is "excessive, as the assessment is greater than the fair market value of the Property; and… unlawful and/or illegal as the assessor included within the property’s assessment non-assessable and/or non-real property items, in violation of the Real Property Tax Law, and in violation of the mandates of the New York State Constitution.” GSK’s 10-year payments in lieu of taxes ended in 2021, so the company's tax bill will either be large, or very large, depending on the lawsuit's outcome. The story says that, "In April of 2021, Durham Sole Assessor Nancy Wyncoop Bower explained in a report to the Town Board that the majority of GSK’s inventory and values had not been updated since 2003." Neither GSK’s attorney, Rebecca M. Speno, nor Town of Durham Attorney Tal Rappleyea would comment for the story. GSK has asked for a Sept. 16 court date in Greene County Supreme Court. Read the full story in Porcupine Soup.